• 1
    Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006; 244: 602-610.
  • 2
    Davies M, Arumugam PJ, Shah VI, et al. The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer. Clin Transl Oncol. 2008; 10: 175-179.
  • 3
    Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007; 370: 2020-2029.
  • 4
    Viehl CT, Guller U, Cecini R, Langer I, Ochsner A, Terracciano L, Riehle HM, Laffer U, Oertli D, Zuber M. Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: Results of the Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer. Ann Surg Oncol. 2012; Feb 10. [Epub ahead of print].
  • 5
    Park SJ, Lee KY, Kim SY. Clinical significance of lymph node micrometastasis in stage I and II colon cancer. Cancer Res Treat. 2008; 40: 75-80.
  • 6
    Bembenek A, Schneider U, Gretschel S, Fischer J, Schlag PM. Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients. World J Surg. 2005; 29: 1172-1175.
  • 7
    Bilchik A, Nissan A, Wainberg Z, et al. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg. 2010; 252: 467-474; discussion 474-466.
  • 8
    Chau I, Cunningham D. Adjuvant therapy in colon cancer—what, when and how? Ann Oncol. 2006; 17: 1347-1359.
  • 9
    Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003; 10: 65-71.
  • 10
    Murawa D, Nowaczyk P, Hunerbein M, et al. One hundred consecutive cases of sentinel lymph node mapping in colon cancer—the results of prospective, single-centre feasibility study with implementation of immunohistochemical staining. Int J Colorectal Dis. 2011; 26: 897-902.
  • 11
    Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA [serial online]. Nucleic Acids Res. 2000; 28: E63.
  • 12
    Schem C, Maass N, Bauerschlag DO, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German Study Group. Virchows Arch. 2009; 454: 203-210.
  • 13
    Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007; 13: 4807-4816.
  • 14
    Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008; 122: 2562-2567.
  • 15
    Alvarenga CA, Paravidino PI, Alvarenga M, et al. Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification. J Clin Pathol. 2011; 64: 493-497.
  • 16
    Osako T, Iwase T, Kimura K, et al. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology. Cancer Cytopathol. 2011; 117: 4365-4374.
  • 17
    Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the 1-step nucleic acid amplification assay. Clin Cancer Res. 2009; 15: 2879-2884.
  • 18
    Yaguchi Y, Sugasawa H, Tsujimoto H, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Ann Surg Oncol. 2011; 18: 2289-2296.
  • 19
    Croner RS, Schellerer V, Demund H, et al. One step nucleic acid amplification (OSNA)—a new method for lymph node staging in colorectal carcinomas [serial online]. J Transl Med. 2010; 8: 83.
  • 20
    Yamamoto H, Sekimoto M, Oya M, et al. OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan. Ann Surg Oncol. 2011; 18: 1891-1898.
  • 21
    Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology. 2004; 51: 1689-1693.
  • 22
    Rosenberg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis. 2004; 19: 430-437.
  • 23
    National Comprehensive Cancer Network. Available at: Accessed April 06, 2012.
  • 24
    College of American Pathologists. Available at: Accessed April 06, 2012.
  • 25
    Washington MK, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med. 2009; 133: 1539-1551.
  • 26
    Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn. 2007; 9: 563-571.
  • 27
    Bilchik AJ, Hoon DS, Saha S, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg. 2007; 246: 568-575; discussion 575-567.
  • 28
    Bosch Roig CE, Rosello-Sastre E, Alonso Hernandez S, et al. Prognostic value of the detection of lymph node micrometastases in colon cancer. Clin Transl Oncol. 2008; 10: 572-578.
  • 29
    Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum. 2002; 45: 750-755; discussion 755-756.
  • 30
    Faerden AE, Sjo OH, Bukholm IR, et al. Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer. Dis Colon Rectum. 2011; 54: 200-206.